Tirupati Starch and Chemicals Limited (BOM:524582)

Ligand Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	-	4.19	9.25	77.59	0.16	0.6
Short-Term Investments	-	3.04	12.42	5.03	6.69	3.92
Trading Asset Securities	-	-	2.81	-	10	-
Cash & Short-Term Investments	7.24	7.24	24.48	82.62	16.86	4.51
Cash Growth	-68.38%	-70.44%	-70.37%	390.13%	273.50%	-15.44%
Accounts Receivable	-	391.66	344.02	330.54	304.27	244.47
Other Receivables	-	-	4.51	9.73	11.27	32.92
Receivables	-	391.66	348.53	340.27	315.54	278.69
Inventory	-	424.59	486.39	137.97	326.37	152.75
Prepaid Expenses	-	-	1.47	1.21	1.23	-
Other Current Assets	-	19.35	88.37	47.95	46.42	32.23
Total Current Assets	-	842.83	949.24	610.01	706.42	468.18
Property, Plant & Equipment	-	1,385	1,194	1,009	771.08	777.53
Other Intangible Assets	-	0.44	0.39	0.01	0.04	0.12
Other Long-Term Assets	-	76.21	120.96	71.93	102.45	86.25
Total Assets	-	2,305	2,264	1,691	1,580	1,332
Accounts Payable	-	184.75	77.8	215.79	336.27	352.37
Accrued Expenses	-	-	43.47	40.89	61.79	37.59
Short-Term Debt	-	-	424.99	189.41	67.32	38.57
Current Portion of Long-Term Debt	-	607.81	156.25	65.26	21.04	12.83
Current Income Taxes Payable	-	10.72	-	3.65	2.07	1.82
Other Current Liabilities	-	88.12	32.69	33.97	21.31	19.54
Total Current Liabilities	-	891.39	735.19	548.97	509.81	462.72
Long-Term Debt	-	750.9	953.76	644.68	678.32	495.08
Long-Term Deferred Tax Liabilities	-	36.98	28.31	21.63	16.85	5.04
Other Long-Term Liabilities	-	0.45	0.45	0.5	0.87	91.44
Total Liabilities	-	1,696	1,729	1,231	1,220	1,054
Common Stock	-	95.89	95.89	80.92	70.01	70.01
Additional Paid-In Capital	-	-	-	45.27	18.42	18.42
Retained Earnings	-	-	-	271.18	209.14	126.5
Comprehensive Income & Other	-	512.65	439.2	62.87	62.86	62.86
Total Common Equity	608.54	608.54	535.09	460.23	360.44	277.8
Shareholders' Equity	608.54	608.54	535.09	460.23	360.44	277.8
Total Liabilities & Equity	-	2,305	2,264	1,691	1,580	1,332
Total Debt	1,359	1,359	1,535	899.35	766.68	546.49
Net Cash (Debt)	-1,351	-1,351	-1,511	-816.73	-749.82	-541.98
Net Cash Per Share	-88.49	-140.91	-173.32	-111.96	-107.10	-87.85
Filing Date Shares Outstanding	32.32	9.56	9.59	8.09	7	7
Total Common Shares Outstanding	32.32	9.56	9.59	8.09	7	7
Working Capital	-	-48.56	214.04	61.04	196.61	5.46
Book Value Per Share	63.65	63.65	55.80	56.88	51.49	39.68
Tangible Book Value	608.1	608.1	534.7	460.21	360.41	277.68
Tangible Book Value Per Share	63.60	63.60	55.76	56.88	51.48	39.66
Land	-	-	72.28	40.25	9.15	9.15
Buildings	-	-	229.16	215.06	216.89	218.94
Machinery	-	-	1,227	824.13	854.24	890.62
Construction In Progress	-	-	268.67	456.44	161.15	70.79

Source: S&P Global Market Intelligence. Standard template. Financial Sources.